BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12940320)

  • 1. Unusual skin lesions in chronic myelomonocytic leukemia.
    McCollum A; Bigelow CL; Elkins SL; Hardy CL; Files JC
    South Med J; 2003 Jul; 96(7):681-4. PubMed ID: 12940320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic myelomonocytic leukemia].
    Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
    Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoplastic skin infiltration in chronic myelomonocytic leukemia].
    Wajs J; Zabielski S; Trawiński J
    Pol Merkur Lekarski; 2001 Nov; 11(65):427-9. PubMed ID: 11852815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
    Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
    Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsing/remitting skin involvement in a patient with chronic myelomonocytic leukemia.
    Paolino G; Rovere-Querini P; Bearzi P; Rizzo N; Mercuri SR
    Int J Dermatol; 2019 Sep; 58(9):e170-e172. PubMed ID: 31115902
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
    Ngo NT; Lampert IA; Naresh KN
    Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
    Mathew RA; Bennett JM; Liu JJ; Komrokji RS; Lancet JE; Naghashpour M; Messina JL; List AF; Moscinski LC; Zhang L
    Leuk Res; 2012 Jan; 36(1):72-80. PubMed ID: 21782240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocytic sarcoma, a diagnostic challenge: 3 pediatric cases].
    Rénard C; Girard S; Pracros JP; Dijoud F; André JM; Mialou V; Bertrand Y
    Arch Pediatr; 2010 Feb; 17(2):149-53. PubMed ID: 19945260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia cutis masquerading as vitiligo.
    Newman MD; Milgraum S
    Cutis; 2008 Feb; 81(2):163-5. PubMed ID: 18441770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myelomonocytic leukemia in adults].
    Baudard M; Delmer A; Zittoun R
    Pathol Biol (Paris); 1997 Sep; 45(7):605-11. PubMed ID: 9404487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple masses on the face of a 58-year-old woman.
    Choi ME; Yang HJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    Int J Dermatol; 2020 May; 59(5):561-562. PubMed ID: 31646611
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune thrombocytopenia in chronic myelomonocytic leukemia.
    Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
    Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
    Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
    Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
    Kaiserling E; Horny HP; Geerts ML; Schmid U
    Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auer Rods in Chronic Myelomonocytic Leukemia Can Change the Diagnosis.
    Gajendra S; Sahoo RK
    Turk J Haematol; 2015 Sep; 32(3):278-9. PubMed ID: 26376597
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
    Martin de Frémont G; Hirsch P; Gimenez de Mestral S; Moguelet P; Ditchi Y; Emile JF; Senet P; Georgin-Lavialle S; Hanslik T; Maurier F; Adedjouma A; Abisror N; Mahevas T; Malard F; Adès L; Fenaux P; Fain O; Chasset F; Mekinian A
    Front Immunol; 2021; 12():715053. PubMed ID: 34671345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.